Effects of mulberry leaf extracts on activity and mRNA expression of five cytochrome P450 enzymes in rat
DOI:
https://doi.org/10.1590/s2175-97902020000X181059Keywords:
: Mulberry leaves. Cytochrome P450. mRNA. Cocktail.Abstract
Adverse side effects of drug-drug interactions induced by human cytochrome P450 (CYP450)
inhibition is an important consideration in drug discovery. Mulberry leaves are of broad popular use for food or remedy purposes, which is believed to contain substances that are beneficial for preventing and alleviating diabetes. However, there is a paucity of information about the effect of mulberry leaves on rat CYP450 enzymes activities and the mRNA expression levels in vivo. The present study aimed to investigate the effect of mulberry leaves on activities of rat CYP450 enzymes (CYP3A4, CYP2C8, CYP2C19, CYP2D6, and CYP1A2) through both probe-drug cocktail approach and real-time polymerase chain reaction (RT-qPCR). The pharmacokinetic results indicated that the aqueous extract of mulberry leaves (AML) exhibited induction effects on CYP3A4 activities, and AML exhibited inhibitory effects on CYP1A2, CYP2D6, and CYP2C8, while no obvious effect was observed on CYP2C19 activity. Additionally, the ethanol extract of mulberry leaves (EML) could induce the activities of CYP3A4. In addition, EML exhibited inhibitory effects on CYP1A2, CYP2D6, and CYP2C19, while no significant change in CYP2C8 activity was observed. Accordingly, the level of mRNA expression of five CYP enzymes were consistent with the result of pharmacokinetic. The results of our study may form a practical strategy for assessing CYP-mediated HDI.
Downloads
References
Berta E, Harangi M, Zsíros N, Nagy EV, Paragh G, Bodor M. Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients. Pharmazie. 2014;69(6):420-423.
Cai R, Liu M, Hu Y, Melton BL, Matheny ME, Xu H,et al. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports. Artif Intell Med. 2017;76:7-15.
Cao L, Kwara A, Greenblatt DJ. Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017;69(12):1762-1772.
Elliot DJ, Suharjono, Lewis BC, Gillam EM, Birkett DJ, Gross AS, et al. Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination. Br J Clin Pharmacol. 2007;64(4):450-457.
Gan J, Chen W, Shen H, Gao L, Hong Y, Tian Y, et al. Repaglinide-gemfibrozil drug interaction:inhibition of repaglinide glucuronidation as a potential additional contributing mechanism. Br J Clin Pharmacol. 2010;70(6):870-880.
Guengerich FP, Turvy CG. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther. 1991;256(3):1189-1194.
Guo YJ, Zheng SL. Effect of myricetin on cytochrome P450 isoforms CYP1A2, CYP2C9 and CYP3A4 in rats. Pharmazie . 2014;69(4):306-310.
Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr. 2017;9:59.
MSA ChilkundaND. Morus alba leaf bioactives modulate Peroxisome proliferator activated receptor γ in the kidney of diabetic rat and impart beneficial effect. J Agric Food Chem. 2018;66(30):7923-7934.
He F, Li Y, Zeng C, Xia C, Xiong Y, Zhang H,et al. Contribution of cytochrome P450 isoforms to gliquidone metabolism in rats and human. Xenobiotica. 2014;44(3):229-234.
Jaakkola T, Laitila J, Neuvonen PJ, Backman JT. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Basic Clin Pharmacol Toxicol. 2006;9(1):44-51.
Jiang B, Meng L, Zhang F, Jin X, Zhang G. Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo. Life Sciences. 2017;189:1-7.
Joh B, Jeon ES, Lim SH, Park YL, Park W, Chae H. Intercultural usage of mori folium: comparison review from a Korean medical perspective. Evid Based Complement Alternat Med. 2015;2015:379268.
Kapoor N, Pant AB, Dhawan A, Dwievedi UN, Seth PK, Parmar D. Cytochrome P450 1A isoenzymes in brain cells: expression and inducibility in cultured rat brain neuronal and glial cells. Life Sciences. 2006;79(25):2387-2394.
Liu R, AbdulHameed MDM, Kumar K, Yu X, Wallqvist A, Reifman J. Data-driven prediction of adverse drug reactions induced by drug-drug interactions. BMC Pharmacol Toxicol. 2017; 18(1):44.
Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, et al. In vitro determination of the effect of andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities. J Nat Med. 2001; 65(3-4):440-7.
Reginald EF. Probing the world of cytochrome P450 enzymes. Molecular Interventions. 2004;4(3):157-62.
Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 1997; 29(1-2):413-580.
Rodeiro I, Donato MT, Jimenez N, Garrido G, Molina-Torres J, Menendez R, et al. Inhibition of human P450 enzymes by natural extracts used in traditional medicine. Phytother Res. 2009; 23(2): 279-82.
Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991;30(13):3247-3255.
Tornio A, Niemi M, Neuvonen PJ, Backman JT. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci. 2012;33(6):312-322.
Wang GQ, Zhu L, Ma ML, Chen XC, Gao Y, Yu TY, et al. Mulberry 1-Deoxynojirimycin inhibits adipogenesis by repression of the ERK/PPARγ signaling pathway in porcine intramuscular adipocytes. Journal of Agricultural and Food Chemistry. 2015;63(27):6212-6220.
Wang J, Zhai T, Chen Y. Effects of honokiol on CYP450 activity and transporter mRNA expression in type 2 diabetic rats. Int J Mol Sci. 2018;19(3):815-825.
Lu YY, Du ZY, Li Y, Wang JL, Zhao MB, Jiang Y, et al. Effects of Baoyuan decoction, a traditional Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats. J Ethnopharmacol. 2018,255:327-335.
Zhang Y, Ren CJ, Lu GB, Mu ZM, Cui WZ, Gao HJ, et al. Anti-diabetic effect of mulberry leaf polysaccharide by inhibiting pancreatic islet cell apoptosis and ameliorating insulin secretory capacity in diabetic rats. Int Immunopharmacol. 2014;22(1):248-57.
Zheng XK, Cao YG, Ke YY, Zhang YL, Li F, Gong JH, et al. Phenolic constituents from the root bark of Morus alba L. and their cardioprotective activity in vitro. Phytochemistry. 2017;135:128-34.
Zhou L, Naraharisetti SB, Liu L, Wang H, Lin YS, Isoherranen N, et al. Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos. 2010;31(4):228-42.
Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41(2):89-295.
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Funding data
-
National Natural Science Foundation of China
Grant numbers 81773988 -
Anhui Provincial Department of Science and Technology
Grant numbers 1301042099
